UROCIT-K 1080 MG
POTASSIUM CITRATE : 1080 MG · DIN 02353997 · MISSION PHARMACAL COMPANY
Health Canada status: MARKETED
What is UROCIT-K?
UROCIT-K 1080 MG contains POTASSIUM CITRATE : 1080 MG. It is listed in the Health Canada Drug Product Database under DIN 02353997, held by MISSION PHARMACAL COMPANY, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 11-Feb-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02353997 |
|---|---|
| Brand name | UROCIT-K |
| Generic / active ingredient | POTASSIUM CITRATE : 1080 MG |
| Manufacturer | MISSION PHARMACAL COMPANY |
| Strength | 1080 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A12BA02 POTASSIUM CITRATE |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Feb-2011 |
| Original market date | 2011-02-11 00:00:00 |
Is POTASSIUM CITRATE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A12BA02 POTASSIUM CITRATE. 1 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| K LYTE TAB LIME & ORANGE FLAV | 975 MG | TABLET (EFFERVESCENT) | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | CANCELLED POST MARKET | DIN 00477117 |
| POLYCITRA-K | 1.193 G / 4.5 G | POWDER | ALZA CORPORATION | CANCELLED POST MARKET | DIN 02163241 |
| POLYCITRA-K | 398 MG / 5 ML | SOLUTION | JANSSEN INC | CANCELLED POST MARKET | DIN 02163233 |
| POTASSIUM 99MG TABLETS | 99 MG | TABLET | BIOFORCE CANADA INC. | CANCELLED POST MARKET | DIN 02075962 |
| POTASSIUM TAB 99MG | 99 MG | TABLET | DA VINCI LABORATORIES, DIVISION OF FOODSCIENCE CORPORATION | CANCELLED POST MARKET | DIN 00519480 |
| UROCIT-K | 540 MG | TABLET (EXTENDED-RELEASE) | MISSION PHARMACAL COMPANY | CANCELLED POST MARKET | DIN 01914022 |
Who else supplies POTASSIUM CITRATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. POTASSIUM CITRATE appears in 158 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.